Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing
2024; Oxford University Press; Linguagem: Inglês
10.1093/cid/ciae121
ISSN1537-6591
AutoresMary K. Hayden, Ibrahim K El Mikati, Kimberly E. Hanson, Janet A. Englund, Romney M. Humphries, Francesca Lee, Mark Loeb, Daniel J. Morgan, Robin Patel, Omar Al Ta’ani, Jamil Nazzal, Shahad Iqneibi, Justin Z. Amarin, Shahnaz Sultan, Yngve Falck‐Ytter, Rebecca L. Morgan, M. Hassan Murad, Adarsh Bhimraj, Reem A. Mustafa,
Tópico(s)COVID-19 Clinical Research Studies
ResumoThe role of serologic testing for SARS-CoV-2 has evolved during the pandemic as seroprevalence in global populations has increased. The Infectious Diseases Society of America (IDSA) convened an expert panel to perform a systematic review of the coronavirus disease 2019 (COVID-19) serology literature and construct updated best practice guidance related to SARS-CoV-2 serologic testing. This guideline is an update to the fourth in a series of rapid, frequently updated COVID-19 guidelines developed by IDSA.
Referência(s)